# EDGAR Filing Document

**Accession Number:** 0001423221
**File Stem:** 0001171843-25-007891
**Filing Date:** 2025-12
**Character Count:** 76315
**Document Hash:** 86a49e7b68e16c4f76052b0bf86634c0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001171843-25-007891.hdr.sgml**: 20251211

**ACCESSION NUMBER**: 0001171843-25-007891

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20251211

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251211

**DATE AS OF CHANGE**: 20251211

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Quanex Building Products CORP
- **CENTRAL INDEX KEY:** 0001423221
- **STANDARD INDUSTRIAL CLASSIFICATION:** ROLLING DRAWING & EXTRUDING OF NONFERROUS METALS [3350]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 261561397
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-33913
- **FILM NUMBER:** 251565198

**BUSINESS ADDRESS:**
- **STREET 1:** 945 BUNKER HILL RD
- **STREET 2:** SUITE 900
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77024
- **BUSINESS PHONE:** 7139614600

**MAIL ADDRESS:**
- **STREET 1:** 945 BUNKER HILL RD
- **STREET 2:** SUITE 900
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77024

?xml version='1.0' encoding='ASCII'? Form 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

### Washington, D.C. 20549
_________________

### FORM 8-K
_________________

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): December 11, 2025
_______________________________

#### Quanex Building Products Corporation
(Exact name of registrant as specified in its charter)

_______________________________

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-33913** | **26-1561397** |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |

---

#### 945 Bunker Hill Road, Suite 900

#### Houston, Texas 77024
(Address of Principal Executive Offices) (Zip Code)

(713) 961-4600

(Registrant's telephone number, including area code)

(Former name or former address, if changed since last report)

_______________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $0.01 per share | NX | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 2.02. Results of Operations and Financial Condition.**

On December 11, 2025, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

**Item 9.01. Financial Statements and Exhibits.**

<br> [99.1](exh_991.htm) [Press Release dated December 11, 2025](exh_991.htm) <br> 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **Quanex Building Products Corporation** | **Quanex Building Products Corporation** |
| Date: December 11, 2025 | By: | <u>/s/ SCOTT ZUEHLKE&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u> |
|  |  | Scott Zuehlke |
|  |  | SVP, CFO and Treasurer |

---

## Exhibit 99.1

**EXHIBIT 99.1**

**Quanex Building Products Announces Fourth Quarter and Full Year 2025 Results**

**Net Sales Growth of ~44% Year-Over-Year** 

**$75 Million of Debt Repaid in Fiscal 2025**

**Cash Provided by Operating Activities Increased ~86% Year-Over-Year**

**Healthy Balance Sheet and Strong Liquidity**

**Integration of Transformative Acquisition Substantially Complete and Thesis Remains Intact**

HOUSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- **<u>Quanex Building Products Corporation</u>** (NYSE:NX) ("Quanex" or the "Company") today announced its results for the three months and twelve months ended October 31, 2025.

The Company reported the following selected financial results:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended October 31,** | **Three Months Ended October 31,** | **Twelve Months Ended October 31,** | **Twelve Months Ended October 31,** |
| ($ in millions, except per share data) | **2025** | **2024** | **2025** | **2024** |
| Net Sales | $489.8 | $492.2 | $1837.6 | $1277.9 |
| Gross Margin | $137.6 | $117.1 | $499.2 | $305.6 |
| &nbsp;&nbsp;*Gross Margin %* | *28.1%* | *23.8%* | *27.2%* | *23.9%* |
| Net income (loss) | $19.6 | ($13.9) | ($250.8) | $33.1 |
| Diluted EPS | $0.43 | ($0.30) | ($5.43) | $0.90 |
| Adjusted Net Income | $38.0 | $38.5 | $106.4 | $97.5 |
| Adjusted Diluted EPS | $0.83 | $0.82 | $2.30 | $2.66 |
| Adjusted EBITDA | $70.9 | $81.1 | $242.9 | $182.4 |
| &nbsp;&nbsp;*Adjusted EBITDA Margin %* | *14.5%* | *16.5%* | *13.2%* | *14.3%* |
| Cash Provided by Operating Activities | $88.3 | $5.5 | $164.9 | $88.8 |
| Free Cash Flow | $66.6 | ($8.2) | $102.3 | $51.7 |

---

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, commented, "Our fiscal 2025 can be summarized by the successful integration of Tyman and the re-segmentation of our operating and reporting structure to align with our long-term strategic objectives, all while navigating a challenging macroeconomic environment. We believe the new segmentation represents a critical step in advancing our long-term *Profitable Growth* strategy and provides a solid framework to drive future revenue and margin expansion, which is consistent with the original thesis for the Tyman acquisition. Inflationary pressures, political instability, high interest rates, tariff uncertainty, housing affordability issues, and geopolitical tensions collectively weakened consumer confidence around the world, causing our end markets to decline meaningfully as compared to 2024. Despite these headwinds, we performed well and achieved another record year of safety performance, with both recordable incident and severity rates reaching historic lows.

"We continue to be encouraged by the overall resilience of the business in the current environment, demonstrated by our strong cash flow, which enabled us to repay a total of $75 million in bank debt in 2025. Our balance sheet remains healthy, and our liquidity improved further during the fourth quarter of 2025. While the integration of the Tyman business is substantially complete, we still believe there is a path to realizing approximately $45 million in cost synergies over time, above our initial projection of $30 million, which has been fully realized. In addition, we have made significant progress towards resolving the isolated operational issue at one of our window and door hardware plants in Mexico and we anticipate that the plant will be fully stabilized in the first half of fiscal 2026. Looking ahead, we continue to be optimistic about our prospects for profitable growth and value creation."

**Fourth Quarter and Fiscal 2025 Results Summary**

Quanex reported net sales of $489.8 million during the three months ended October 31, 2025, which represents a decrease of 0.5% compared to $492.2 million for the same period of 2024, mainly due to lower volume. The Company reported net sales of $1.84 billion during the twelve months ended October 31, 2025, which represents an increase of 43.8% compared to $1.28 billion for the same period of 2024. The increase for the full year was driven by the contribution from the Tyman acquisition that closed on August 1, 2024. In its Hardware Solutions segment, Quanex reported an increase of 1.4% in net sales for the fourth quarter of 2025, mostly due to foreign exchange and tariff pass-throughs, and an increase of 96.7% in net sales for the full year. In its Extruded Solutions segment, Quanex reported a decrease of 6.4% in net sales for the fourth quarter of 2025, driven by lower volumes, and an increase of 15.5% in net sales for the full year. For its Custom Solutions segment, the Company reported an increase of 2.1% in net sales for the fourth quarter of 2025, largely due to improved pricing, and an increase of 25.5% in net sales for the full year. (See Sales Analysis table for additional information)

On a consolidated basis, the decrease in adjusted earnings for the fourth quarter of 2025 was mainly due to lower volumes related to ongoing macroeconomic uncertainty coupled with low consumer confidence and operational challenges related to Quanex's window and door hardware plant in Monterrey, Mexico. The increase in adjusted earnings for the full year 2025, was primary attributable to the contribution from the Tyman acquisition combined with the realization of related cost synergies.

**Balance Sheet & Liquidity Update**

As of October 31, 2025, the Company had total debt of $703.9 million and Quanex's leverage ratio of Net Debt to LTM Adjusted EBITDA was unchanged at 2.6x, compared to the prior quarter. As of October 31, 2025, Quanex reported a LTM Net Loss of $250.8 million, mainly due to the non-cash goodwill impairment reported in the third quarter, and LTM Adjusted EBITDA of $242.9 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The Company's liquidity increased to $372.4 million as of October 31, 2025, consisting of $76.0 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

**Share Repurchases**

Quanex's Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 199,712 shares of common stock for approximately $3.1 million at an average price of $15.58 per share during the three months ended October 31, 2025. Quanex repurchased 1,709,119 shares of common stock for approximately $32.4 million at an average price of $18.93 per share during the twelve months ended October 31, 2025. As of October 31, 2025, approximately $30.5 million remained under the existing share repurchase authorization.

**Outlook**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Mr. Wilson stated, "Our long-term view continues to be favorable as the underlying fundamentals for the residential housing market remain positive. We enter fiscal 2026 with a cautious outlook due to the ongoing macroeconomic challenges, but we are optimistic that demand for our products will improve as consumer confidence is restored over time. Our current view is that fiscal 2026 could be flat compared to fiscal 2025 from a revenue and EBITDA perspective, with puts and takes, but the first half of 2026 may be more challenged than the first half of 2025, which would imply a somewhat improved second half year-over-year. Having said that, and consistent with the last few years, based on current macro indicators, recent conversations with our customers, limited transparency, and varying opinions on the macroeconomic outlook for 2026, we are again taking a measured approach to guidance. We believe it would be premature to give official guidance at this time and intend to re-visit guidance for 2026 when we report earnings for the first quarter. As macroeconomic uncertainty subsides and consumer confidence improves, we believe our team is well positioned to capitalize on pent-up demand. In the meantime, we will stay focused on the things that we can control, with an emphasis on generating cash to continue paying down debt and opportunistically repurchasing our stock."

**Conference Call and Webcast Information**

The Company has also scheduled a conference call for Friday, December 12, 2025 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex's website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register-conf.media-server.com/register/BI74e5fd99c2e14c3896a48692a347cd12

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company's website at http://www.quanex.com in the Investors section under Presentations & Events.

**About Quanex** 

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

**Non-GAAP Terminology Definitions and Disclaimers**

Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex's leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company's credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company's residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company's financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company's financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

**Forward Looking Statements**

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that use the words "estimated," "expect," "could," "should," "believe," "will," "might," or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: the Company's ability to resolve an isolated operational issue at its window and door hardware plant located in Monterrey, Mexico, timing estimates or any other expectations related to the acquisition of Tyman, Quanex's future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to the Company's industry, and Quanex's future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. Therefore, you should not rely on any of these forward-looking statements. For a complete discussion of factors that may affect the Company's future performance, please refer to Quanex's Annual Report on Form 10-K for the fiscal year ended October 31, 2024, and the Company's Quarterly Reports on Form 10-Q under the sections entitled "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors". Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements, whether written or oral, to reflect new information, developments or events.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **CONDENSED CONSOLIDATED STATEMENTS OF INCOME**<br>(In thousands, except per share data)<br>(Unaudited) | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME**<br>(In thousands, except per share data)<br>(Unaudited) | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME**<br>(In thousands, except per share data)<br>(Unaudited) | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME**<br>(In thousands, except per share data)<br>(Unaudited) | **CONDENSED CONSOLIDATED STATEMENTS OF INCOME**<br>(In thousands, except per share data)<br>(Unaudited) |
|  | **Three Months Ended October 31,** | **Three Months Ended October 31,** | **Twelve Months Ended October 31,** | **Twelve Months Ended October 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Net sales | $489846 | $492161 | $1837641 | $1277862 |
| Cost of sales | 352284 | 375111 | 1338413 | 972238 |
| Selling, general and administrative | 69008 | 86891 | 277261 | 190470 |
| Restructuring (credit) charges | (16) |  | 10191 |  |
| Depreciation and amortization | 25630 | 27329 | 103444 | 60328 |
| Goodwill impairment charges | - | - | 302284 | - |
| Operating income (loss) | 42940 | 2830 | (193952) | 54826 |
| Interest expense | (13468) | (17697) | (55812) | (20593) |
| Other, net | 5246 | (2671) | 7171 | 7849 |
| Income (loss) before income taxes | 34718 | (17538) | (242593) | 42082 |
| Income tax (expense) benefit | (15147) | 3621 | (8213) | (9023) |
| Net income (loss) | $19571 | $(13917) | $(250806) | $33059 |
| Earnings (loss) per common share, basic | $0.43 | $(0.30) | $(5.43) | $0.91 |
| Earnings (loss) per common share, diluted | $0.43 | $(0.30) | $(5.43) | $0.90 |
| Weighted average common shares outstanding: |  |  |  |  |
| Basic | 45502 | 47015 | 46170 | 36416 |
| Diluted | 45593 | 47015 | 46170 | 36648 |
| Cash dividends per share | $0.08 | $0.08 | $0.32 | $0.32 |

---

---

| | | |
|:---|:---|:---|
| **QUANEX BUILDING PRODUCTS CORPORATION**<br>**CONDENSED CONSOLIDATED BALANCE SHEETS**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**CONDENSED CONSOLIDATED BALANCE SHEETS**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**CONDENSED CONSOLIDATED BALANCE SHEETS**<br>(In thousands)<br>(Unaudited) |
|  | **October 31, 2025** | **October 31, 2024** |
| **ASSETS** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $76018 | $97744 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restricted Cash | 2100 | 5251 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 205384 | 197689 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories | 254122 | 275550 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes receivable |  | 5937 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid assets | 32387 | 23419 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 3764 | 5678 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 573775 | 611268 |
| Property, plant and equipment, net | 411591 | 402466 |
| Operating lease right-of-use assets | 154866 | 126715 |
| Deferred tax assets | 2706 | 3845 |
| Goodwill | 271346 | 574711 |
| Intangible assets, net | 549137 | 597909 |
| Other assets | 4812 | 2874 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $1968233 | $2319788 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $131307 | $124404 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 95155 | 103623 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 12076 | 6620 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current maturities of long-term debt | 27561 | 25745 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current operating lease liabilities | 15446 | 12475 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 281545 | 272867 |
| Long-term debt | 665268 | 737198 |
| Noncurrent operating lease liabilities | 145459 | 117560 |
| Deferred income taxes | 135993 | 162304 |
| Other liabilities | 13789 | 19113 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1242054 | 1309042 |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock | 512 | 513 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in-capital | 700029 | 701008 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retained earnings | 164710 | 430405 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (35439) | (46428) |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock at cost | (103633) | (74752) |
| &nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 726179 | 1010746 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $1968233 | $2319788 |

---

---

| | | |
|:---|:---|:---|
| **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW**<br>(In thousands)<br>(Unaudited) | **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW**<br>(In thousands)<br>(Unaudited) | **CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW**<br>(In thousands)<br>(Unaudited) |
|  | **Twelve Months Ended October 31,** | **Twelve Months Ended October 31,** |
|  | **2025** | **2024** |
| **Operating activities:** |  |  |
| &nbsp;&nbsp;Net (loss) income | $(250806) | $33059 |
| &nbsp;&nbsp;Adjustments to reconcile net (loss) income to cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 103444 | 60328 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss (gain) on disposition of capital assets | 613 | (5218) |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation | 3685 | 2952 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax | (18535) | (15336) |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment charge | 302284 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Charge for deferred loan costs and debt discount |  | 3469 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on deal contingent foreign exchange forward currency contract |  | (6512) |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | 4561 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | 7114 | 4495 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in accounts receivable | (6878) | 973 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in inventory | 23553 | 33484 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Increase) decrease in other current assets | (3653) | 4297 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase (decrease) in accounts payable | 3313 | (35824) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Decrease) increase in accrued liabilities | (9657) | 6250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Increase in current income taxes payable | 11108 | 9139 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Decrease in other long-term liabilities | (4693) | (7155) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | (556) | 411 |
| Cash provided by operating activities | 164897 | 88812 |
| **Investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Business acquisition |  | (398554) |
| &nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (62642) | (37086) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from disposition of capital assets | 634 | 15046 |
| Cash used for investing activities | (62008) | (420594) |
| **Financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Borrowings under credit facilities | 190000 | 785000 |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayments of credit facility borrowings | (265000) | (83750) |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt issuance costs |  | (13808) |
| &nbsp;&nbsp;&nbsp;&nbsp;Repayments of other long-term debt | (4045) | (296206) |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock dividends paid | (14889) | (11972) |
| &nbsp;&nbsp;&nbsp;&nbsp;Issuance of common stock | 214 | 573 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from deal contingent foreign exchange forward currency contract |  | 6512 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payroll tax paid to settle shares forfeited upon vesting of stock | (1400) | (1193) |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase of treasury stock | (32360) | - |
| Cash (used for) provided by financing activities | (127480) | 385156 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of exchange rate changes on cash and cash equivalents | (286) | (8853) |
| (Decrease) Increase in cash, cash equivalents and restricted cash | (24877) | 44521 |
| Cash, cash equivalents and restricted cash at beginning of period | 102995 | 58474 |
| Cash, cash equivalents and restricted cash at end of period | $78118 | $102995 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **QUANEX BUILDING PRODUCTS CORPORATION**<br>**FREE CASH FLOW AND NET DEBT RECONCILIATION**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**FREE CASH FLOW AND NET DEBT RECONCILIATION**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**FREE CASH FLOW AND NET DEBT RECONCILIATION**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**FREE CASH FLOW AND NET DEBT RECONCILIATION**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**FREE CASH FLOW AND NET DEBT RECONCILIATION**<br>(In thousands)<br>(Unaudited) |
| The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. |
|  | **Three Months Ended October 31,** | **Three Months Ended October 31,** | **Twelve Months Ended October 31,** | **Twelve Months Ended October 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
| Cash provided by operating activities | $88254 | $5479 | 164897 | $88812 |
| Capital expenditures | (21646) | (13651) | (62642) | (37086) |
| **Free Cash Flow** | **$66608** | **($8172)** | **102255** | **$51726** |
| The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. |
|  | **As of October 31,** | **As of October 31,** |  |  |
|  | **2025** | **2024** |  |  |
| Term loan facility | $468750 | $493750 |  |  |
| Revolving credit facility | 172500 | 222500 |  |  |
| Finance lease obligations <sup>(1)</sup> | 62619 | 60676 |  |  |
| Total debt <sup>(2)</sup> | 703869 | 776926 |  |  |
| Less: Cash and cash equivalents | 76018 | 97744 |  |  |
| **Net Debt** | **627851** | **679182** |  |  |
| (1) Includes $56.4 million and $50.3 million in real estate lease liabilities considered finance leases under U.S. GAAP as of October 31, 2025 and 2024, respectively. | (1) Includes $56.4 million and $50.3 million in real estate lease liabilities considered finance leases under U.S. GAAP as of October 31, 2025 and 2024, respectively. | (1) Includes $56.4 million and $50.3 million in real estate lease liabilities considered finance leases under U.S. GAAP as of October 31, 2025 and 2024, respectively. | (1) Includes $56.4 million and $50.3 million in real estate lease liabilities considered finance leases under U.S. GAAP as of October 31, 2025 and 2024, respectively. | (1) Includes $56.4 million and $50.3 million in real estate lease liabilities considered finance leases under U.S. GAAP as of October 31, 2025 and 2024, respectively. |
| (2) Excludes outstanding letters of credit. | (2) Excludes outstanding letters of credit. | (2) Excludes outstanding letters of credit. | (2) Excludes outstanding letters of credit. | (2) Excludes outstanding letters of credit. |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **QUANEX BUILDING PRODUCTS CORPORATION**<br>**NON-GAAP FINANCIAL MEASURE DISCLOSURE**<br>**LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION**<br>(In thousands, except per share data)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**NON-GAAP FINANCIAL MEASURE DISCLOSURE**<br>**LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION**<br>(In thousands, except per share data)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**NON-GAAP FINANCIAL MEASURE DISCLOSURE**<br>**LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION**<br>(In thousands, except per share data)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**NON-GAAP FINANCIAL MEASURE DISCLOSURE**<br>**LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION**<br>(In thousands, except per share data)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**NON-GAAP FINANCIAL MEASURE DISCLOSURE**<br>**LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION**<br>(In thousands, except per share data)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**NON-GAAP FINANCIAL MEASURE DISCLOSURE**<br>**LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION**<br>(In thousands, except per share data)<br>(Unaudited) |
| **Reconciliation of Last Twelve Months Adjusted EBITDA** | **Three Months Ended<br>October 31, 2025** | **Three Months Ended <br>July 31, 2025** | **Three Months Ended<br>April 30, 2025** | **Three Months Ended <br>January 31, 2025** | **Total** |
|  | **Reconciliation** | **Reconciliation** | **Reconciliation** | **Reconciliation** | **Reconciliation** |
| Net income (loss) as reported | $19571 | $(276007) | $20515 | $(14885) | $(250806) |
| Income tax expense (benefit) | 15147 | (8191) | 6307 | (5050) | 8213 |
| Other, net | (5246) | (855) | 159 | (1229) | (7171) |
| Interest expense | 13468 | 14218 | 13940 | 14186 | 55812 |
| Depreciation and amortization | 25630 | 33882 | 19192 | 24740 | 103444 |
| Asset impairment charges | - | 302284 | - | - | 302284 |
| EBITDA | 68570 | 65331 | 60113 | 17762 | 211776 |
| Cost of sales <sup>(1),(2)</sup> | 308 | 148 | 976 | 9007 | 10439 |
| Selling, general and administrative <sup>(1),(3)</sup> | 2056 | 3449 | 1110 | 3869 | 10484 |
| Restructuring (credit) charges <sup>(4)</sup> | (16) | 1367 | 936 | 7904 | 10191 |
| Adjusted EBITDA | $70918 | $70295 | $63135 | $38542 | $242890 |
| (1) Expense related to plant closure/relocation. |  |  |  |  |  |
| (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. |  |  |  |  |
| (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. |  |  |  |  |
| (4) Restructuring charges related to severance. |  |  |  |  |  |

---

**QUANEX BUILDING PRODUCTS CORPORATION**

**NON-GAAP FINANCIAL MEASURE DISCLOSURE**

(In thousands, except per share data)

(Unaudited)

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Reconciliation of Adjusted Net Income and Adjusted EPS** | **Three Months Ended <br>October 31, 2025** | **Three Months Ended <br>October 31, 2025** | | **Three Months Ended <br>October 31, 2024** | **Three Months Ended <br>October 31, 2024** | | **Twelve Months Ended<br>October 31, 2025** | **Twelve Months Ended<br>October 31, 2025** | | **Twelve Months Ended<br>October 31, 2024** | **Twelve Months Ended<br>October 31, 2024** | |
|  | **Net Income** | **Diluted EPS** | | **Net Income** | **Diluted EPS** | | **Net Income** | **Diluted EPS** | | **Net Income** | **Diluted EPS** | |
| Net income (loss) as reported | $19571 | $0.43 |  | $(13917) | $(0.30) |  | $(250806) | $(5.43) |  | $33059 | $0.90 |  |
| Net income (loss) reconciling items from below | 18454 | $0.40 |  | 52440 | $1.12 |  | 357209 | $7.73 |  | 64462 | $1.76 |  |
| Adjusted net income and adjusted EPS | $38025 | $0.83 |  | $38523 | $0.82 |  | $106403 | $2.30 |  | $97521 | $2.66 |  |
| **Reconciliation of Adjusted EBITDA** | **Three Months Ended<br>October 31, 2025** | **Three Months Ended<br>October 31, 2025** |  | **Three Months Ended <br>October 31, 2024** | **Three Months Ended <br>October 31, 2024** |  | **Twelve Months Ended<br>October 31, 2025** | **Twelve Months Ended<br>October 31, 2025** |  | **Twelve Months Ended<br>October 31, 2024** | **Twelve Months Ended<br>October 31, 2024** |  |
|  | **Reconciliation** |  |  | **Reconciliation** |  |  | **Reconciliation** |  |  | **Reconciliation** |  |  |
| Net income (loss)as reported | $19571 |  |  | $(13917) |  |  | $(250806) |  |  | $33059 |  |  |
| Income tax expense (benefit) | 15147 |  |  | (3621) |  |  | 8213 |  |  | 9023 |  |  |
| Other, net | (5246) |  |  | 2671 |  |  | (7171) |  |  | (7849) |  |  |
| Interest expense | 13468 |  |  | 17697 |  |  | 55812 |  |  | 20593 |  |  |
| Depreciation and amortization | 25630 |  |  | 27329 |  |  | 103444 |  |  | 60328 |  |  |
| Asset impairment charges | - |  |  | - |  |  | 302284 |  |  | - |  |  |
| EBITDA | 68570 |  |  | 30159 |  |  | 211776 |  |  | 115154 |  |  |
| EBITDA reconciling items from below | 2348 |  |  | 50891 |  |  | 31114 |  |  | 67229 |  |  |
| Adjusted EBITDA | $70918 |  |  | $81050 |  |  | $242890 |  |  | $182383 |  |  |
| **Reconciling Items** | **Three Months Ended<br>October 31, 2025** | **Three Months Ended<br>October 31, 2025** |  | **Three Months Ended<br>October 31, 2024** | **Three Months Ended<br>October 31, 2024** |  | **Twelve Months Ended<br>October 31, 2025** | **Twelve Months Ended<br>October 31, 2025** |  | **Twelve Months Ended<br>October 31, 2024** | **Twelve Months Ended<br>October 31, 2024** |  |
|  | **Income Statement** | **Reconciling Items** |  | **Income Statement** | **Reconciling Items** |  | **Income Statement** | **Reconciling Items** |  | **Income Statement** | **Reconciling Items** |  |
| Net sales | $489846 | $- |  | $492161 | $- |  | $1837641 | $- |  | $1277862 | $- |  |
| Cost of sales | 352284 | (308) | *(1)* | 375111 | (29363) | *(1),(2)* | 1338413 | (10439) | *(1),(2)* | 972238 | (31501) | *(1),(2)* |
| Selling, general and administrative | 69008 | (2056) | *(1),(3)* | 86891 | (21528) | *(1),(3),(4)* | 277261 | (10484) | *(1),(3)* | 190470 | (35728) | *(1),(3),(4)* |
| Restructuring credit (charges) | (16) | 16 | *(5)* | - | - |  | 10191 | (10191) | *(5)* | - | - | *(5)* |
| EBITDA | 68570 | 2348 |  | 30159 | 50891 |  | 211776 | 31114 |  | 115154 | 67229 |  |
| Goowill impairment charges |  |  |  |  |  |  | 302284 | (302284) | *(6)* |  |  |  |
| Depreciation and amortization | 25630 | (9839) | *(7)* | 27329 | (12623) | *(7)* | 103444 | (46547) | *(7)* | 60328 | (21605) | *(7)* |
| Operating income (loss) | 42940 | 12187 |  | 2830 | 63514 |  | (193952) | 379945 |  | 54826 | 88834 |  |
| Interest expense | (13468) |  |  | (17697) |  |  | (55812) |  |  | (20593) |  |  |
| Other, net | 5246 | 238 | *(8)* | (2671) | 3271 | *(8)* | 7171 | 120 | *(8)* | 7849 | (6738) | *(8)* |
| Income (loss) before income taxes | 34718 | 12425 |  | (17538) | 66785 |  | (242593) | 380065 |  | 42082 | 82096 |  |
| Income tax (expense) benefit | (15147) | 6029 | *(9)* | 3621 | (14345) | *(9)* | (8213) | (22856) | *(9)* | (9023) | (17634) | *(9)* |
| Net income (loss) | $19571 | $18454 |  | $(13917) | $52440 |  | $(250806) | $357209 |  | $33059 | $64462 |  |
| Diluted earnings (loss) per share | $0.43 |  |  | $(0.30) |  |  | $(5.43) |  |  | $0.90 |  |  |
| (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. | (1) Expense related to plant closure/relocation. |
| (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. | (2) Amortization of step-up for purchase price adjustments on inventory. |
| (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. | (3) Transaction, advisory fees, reorganization costs and product recall expenses. |
| (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. | (4) Amortization of step-up for purchase price adjustments on accounts receivable. |
| (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. | (5) Restructuring credit (charges) related to severance and disposal of software. |
| (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. | (6) Goodwill impairment. |
| (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. | (7) Amortization expense related to intangible assets and onetime deprecation adjustment. |
| (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. | (8) Pension settlement refund and foreign currency transaction gains. |
| (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. | (9) Tax impact of net income reconciling items. |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA**<br>(In thousands)<br>(Unaudited) |
| This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. |
|  | **Hardware Solutions** | **Extruded Solutions** | **Custom Solutions** | **Unallocated Corp & Other** | **Total** |
| **Three months ended October 31, 2025** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $226883 | $168603 | $103401 | $(9041) | $489846 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 168881 | 114227 | 78561 | (9385) | 352284 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin | 58002 | 54376 | 24840 | 344 | 137562 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *25.6 %* | *32.3 %* | *24.0 %* |  | *28.1 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative <sup>(1)</sup> | 29439 | 22795 | 14117 | 2657 | 69008 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring (credit) charges | (219) |  | 179 | 24 | (16) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 12863 | 7138 | 5555 | 74 | 25630 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | 15919 | 24443 | 4989 | (2411) | 42940 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 12863 | 7138 | 5555 | 74 | 25630 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA | 28782 | 31581 | 10544 | (2337) | 68570 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expense related to plant relocation (Cost of sales) | 308 |  |  |  | 308 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Credit related to plant relocation (SG&A) | (25) |  |  |  | (25) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction, advisory fees, reorganization costs, and product recall expenses | 113 | 87 | 31 | 1850 | 2081 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring (credit) charges related to severance | (219) | - | 179 | 24 | (16) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $28959 | $31668 | $10754 | $(463) | $70918 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *12.8 %* | *18.8 %* | *10.4 %* |  | *14.5 %* |
| **Three months ended October 31, 2024** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $223712 | $180135 | $101240 | $(12926) | $492161 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 183427 | 126653 | 77746 | (12715) | 375111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin | 40285 | 53482 | 23494 | (211) | 117050 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *18.0 %* | *29.7 %* | *23.2 %* |  | *23.8 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative <sup>(1)</sup> | 32860 | 12367 | 11612 | 30052 | 86891 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 13049 | 8503 | 5663 | 114 | 27329 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating (loss) income | (5624) | 32612 | 6219 | (30377) | 2830 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 13049 | 8503 | 5663 | 114 | 27329 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA | 7425 | 41115 | 11882 | (30263) | 30159 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expense related to plant closure (Cost of sales) |  | 887 |  |  | 887 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain related to plant closure (SG&A) |  | (5299) |  |  | (5299) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of step-up for purchase price adjustments on inventory and accounts receivable | 24240 | 1137 | 3699 |  | 29076 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction and advisory fees | 268 | 88 | - | 25871 | 26227 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $31933 | $37928 | $15581 | $(4392) | $81050 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *14.3 %* | *21.1 %* | *15.4 %* |  | *16.5 %* |
| **Twelve months ended October 31, 2025** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $841674 | $646627 | $388210 | $(38870) | $1837641 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 635481 | 440141 | 298316 | (35525) | 1338413 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin | 206193 | 206486 | 89894 | (3345) | 499228 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *24.5 %* | *31.9 %* | *23.2 %* |  | *27.2 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative <sup>(1)</sup> | 128009 | 83716 | 48273 | 17263 | 277261 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges | 7936 | 34 | 205 | 2016 | 10191 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 51681 | 29204 | 21248 | 1311 | 103444 |
| &nbsp;&nbsp;&nbsp;&nbsp;Goodwill impairment charges | 163198 | 54934 | 84152 | - | 302284 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating (loss) income | (144631) | 38598 | (63984) | (23935) | (193952) |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 51681 | 29204 | 21248 | 1311 | 103444 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset impairment charges | 163198 | 54934 | 84152 | - | 302284 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA | 70248 | 122736 | 41416 | (22624) | 211776 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expense related to plant relocation (Cost of sales) | 1432 |  |  |  | 1432 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expense related to plant relocation (SG&A) | 221 |  |  |  | 221 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of step-up for purchase price adjustments on inventory | 7453 | 365 | 1189 |  | 9007 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction, advisory fees, reorganization costs, and product recall expenses | 1510 | 263 | 81 | 8409 | 10263 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges related to severance and disposal of software | 7936 | 34 | 205 | 2016 | 10191 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $88800 | $123398 | $42891 | $(12199) | $242890 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *10.6 %* | *19.1 %* | *11.0 %* |  | *13.2 %* |
| **Twelve months ended October 31, 2024** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $427839 | $559995 | $309441 | $(19413) | $1277862 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 349379 | 389760 | 252111 | (19012) | 972238 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin | 78460 | 170235 | 57330 | (401) | 305624 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *18.3 %* | *30.4 %* | *18.5 %* |  | *23.9 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative <sup>(1)</sup> | 51564 | 58100 | 31068 | 49738 | 190470 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring charges |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 16580 | 25119 | 18348 | 281 | 60328 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | 10316 | 87016 | 7914 | (50420) | 54826 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 16580 | 25119 | 18348 | 281 | 60328 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA | 26896 | 112135 | 26262 | (50139) | 115154 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expense related to plant closure (Cost of sales) |  | 3025 |  |  | 3025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain related to plant closure (SG&A) |  | (4196) |  |  | (4196) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of step-up for purchase price adjustments on inventory and accounts receivable | 24240 | 1137 | 3699 |  | 29076 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction and advisory fees | 268 | 88 | - | 38968 | 39324 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $51404 | $112189 | $29961 | $(11171) | $182383 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *12.0 %* | *20.0 %* | *9.7 %* |  | *14.3 %* |
| (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. | (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. | (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. | (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. | (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. | (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. |
| (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. | (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. | (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. | (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. | (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. | (1) Includes stock-based compensation (credit) expense for the three and twelve months ended October 31, 2025, respectively of ($1.2) million and $2.4 million, and $2.0 million and $7.4 million for the comparable prior year periods. |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA RECONCILIATION**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA RECONCILIATION**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA RECONCILIATION**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA RECONCILIATION**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA RECONCILIATION**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA RECONCILIATION**<br>(In thousands)<br>(Unaudited) | **QUANEX BUILDING PRODUCTS CORPORATION**<br>**SELECTED SEGMENT DATA RECONCILIATION**<br>(In thousands)<br>(Unaudited) |
| This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated December 12, 2024 for the three and twelve months ended October 31, 2024, to the current presentation. | This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated December 12, 2024 for the three and twelve months ended October 31, 2024, to the current presentation. | This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated December 12, 2024 for the three and twelve months ended October 31, 2024, to the current presentation. | This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated December 12, 2024 for the three and twelve months ended October 31, 2024, to the current presentation. | This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated December 12, 2024 for the three and twelve months ended October 31, 2024, to the current presentation. | This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated December 12, 2024 for the three and twelve months ended October 31, 2024, to the current presentation. | This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated December 12, 2024 for the three and twelve months ended October 31, 2024, to the current presentation. |
|  | **NA Fenestration** | **EU Fenestration** | **NA Cabinet Components** | **Tyman** | **Unallocated Corp & Other** | **Total** |
| **Three months ended October 31, 2024** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $172031 | $65075 | $52761 | $203435 | $(1141) | $492161 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 127448 | 40258 | 44136 | 163946 | (677) | 375111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin | 44583 | 24817 | 8625 | 39489 | (464) | 117050 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *25.9 %* | *38.1 %* | *16.3 %* | *19.4 %* |  | *23.8 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 10072 | 8310 | 5373 | 44453 | 18683 | 86891 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 5107 | 2715 | 3004 | 16438 | 65 | 27329 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | 29404 | 13792 | 248 | (21402) | (19212) | 2830 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 5107 | 2715 | 3004 | 16438 | 65 | 27329 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA | 34511 | 16507 | 3252 | (4964) | (19147) | 30159 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expense related to plant closure (Cost of sales) | 887 |  |  |  |  | 887 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gain related to plant closure (SG&A) | (5299) |  |  |  |  | (5299) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of step-up for purchase price adjustments on inventory and accounts receivable |  |  |  | 29076 |  | 29076 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction and advisory fees | - | - | - | 10359 | 15868 | 26227 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $30099 | $16507 | $3252 | $34471 | $(3279) | $81050 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *17.5 %* | *25.4 %* | *6.2 %* | *16.9 %* |  | *16.5 %* |
|  | **Hardware Solutions<sup>(1)</sup>** | **Extruded Solutions<sup>(2)</sup>** | **Custom Solutions<sup>(3)</sup>** | **Tyman** | **Unallocated Corp & Other** | **Total** |
| **Three months ended October 31, 2024** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $223712 | $180135 | $101240 | $- | $(12926) | $492161 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 183427 | 126653 | 77746 | - | (12715) | 375111 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin | 40285 | 53482 | 23494 |  | (211) | 117050 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *18.0 %* | *29.7 %* | *23.2 %* |  |  | *23.8 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 32860 | 12367 | 11612 |  | 30052 | 86891 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 13049 | 8503 | 5663 | - | 114 | 27329 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income | (5624) | 32612 | 6219 |  | (30377) | 2830 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 13049 | 8503 | 5663 | - | 114 | 27329 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA | 7425 | 41115 | 11882 |  | (30263) | 30159 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expense related to plant closure (Cost of sales) |  | 887 |  |  |  | 887 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gain related to plant closure (SG&A) |  | (5299) |  |  |  | (5299) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of step-up for purchase price adjustments on inventory and accounts receivable | 24240 | 1137 | 3699 |  |  | 29076 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction and advisory fees | 268 | 88 | - | - | 25871 | 26227 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $31933 | $37928 | $15581 | $- | $(4392) | $81050 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *14.3 %* | *21.1 %* | *15.4 %* |  |  | *16.5 %* |
|  | **NA Fenestration** | **EU Fenestration** | **NA Cabinet Components** | **Tyman** | **Unallocated Corp & Other** | **Total** |
| **Twelve months ended October 31, 2024** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $650058 | $230712 | $198424 | $203435 | $(4767) | $1277862 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 498378 | 144585 | 168414 | 163946 | (3085) | 972238 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin | 151680 | 86127 | 30010 | 39489 | (1682) | 305624 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *23.3 %* | *37.3 %* | *15.1 %* | *19.4 %* |  | *23.9 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 56630 | 31318 | 20727 | 44453 | 37342 | 190470 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 20994 | 10420 | 12244 | 16438 | 232 | 60328 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | 74056 | 44389 | (2961) | (21402) | (39256) | 54826 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 20994 | 10420 | 12244 | 16438 | 232 | 60328 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA | 95050 | 54809 | 9283 | (4964) | (39024) | 115154 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Expense related to plant closure (Cost of sales) | 3025 |  |  |  |  | 3025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gain related to plant closure (SG&A) | (4196) |  |  |  |  | (4196) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of step-up for purchase price adjustments on inventory and accounts receivable |  |  |  | 29076 |  | 29076 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction and advisory fees | - | - | - | 10359 | 28965 | 39324 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $93879 | $54809 | $9283 | $34471 | $(10059) | $182383 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *14.4 %* | *23.8 %* | *4.7 %* | *16.9 %* |  | *14.3 %* |
|  | **Hardware Solutions<sup>(1)</sup>** | **Extruded Solutions<sup>(2)</sup>** | **Custom Solutions<sup>(3)</sup>** | **Tyman** | **Unallocated Corp & Other** | **Total** |
| **Twelve months ended October 31, 2024** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $427839 | $559995 | $309441 | $- | $(19413) | $1277862 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | 349379 | 389760 | 252111 | - | (19012) | 972238 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross Margin | 78460 | 170235 | 57330 |  | (401) | 305624 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Gross Margin %* | *18.3 %* | *30.4 %* | *18.5 %* |  |  | *23.9 %* |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 51564 | 58100 | 31068 |  | 49738 | 190470 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 16580 | 25119 | 18348 | - | 281 | 60328 |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income (loss) | 10316 | 87016 | 7914 |  | (50420) | 54826 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 16580 | 25119 | 18348 | - | 281 | 60328 |
| &nbsp;&nbsp;&nbsp;&nbsp;EBITDA | 26896 | 112135 | 26262 |  | (50139) | 115154 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on damage to manufacturing facilities (Cost of sales) |  | 3025 |  |  |  | 3025 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net gain related to plant closure (SG&A) |  | (4196) |  |  |  | (4196) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of step-up for purchase price adjustments on inventory and accounts receivable | 24240 | 1137 | 3699 |  |  | 29076 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Transaction and advisory fees | 268 | 88 | - | - | 38968 | 39324 |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjusted EBITDA | $51404 | $112189 | $29961 | $- | $(11171) | $182383 |
| &nbsp;&nbsp;&nbsp;&nbsp;*Adjusted EBITDA Margin %* | *12.0 %* | *20.0 %* | *9.7 %* |  |  | *14.3 %* |
| (1) Contains a portion of the previously reported NA Fenestration segment. | (1) Contains a portion of the previously reported NA Fenestration segment. | (1) Contains a portion of the previously reported NA Fenestration segment. | (1) Contains a portion of the previously reported NA Fenestration segment. | (1) Contains a portion of the previously reported NA Fenestration segment. | (1) Contains a portion of the previously reported NA Fenestration segment. | (1) Contains a portion of the previously reported NA Fenestration segment. |
| (2) Contains a portion of the NA Fenestration segment and the EU Fenestration segment. | (2) Contains a portion of the NA Fenestration segment and the EU Fenestration segment. | (2) Contains a portion of the NA Fenestration segment and the EU Fenestration segment. | (2) Contains a portion of the NA Fenestration segment and the EU Fenestration segment. | (2) Contains a portion of the NA Fenestration segment and the EU Fenestration segment. | (2) Contains a portion of the NA Fenestration segment and the EU Fenestration segment. | (2) Contains a portion of the NA Fenestration segment and the EU Fenestration segment. |
| (3) Contains a portion of the NA Fenestration segment and the NA Cabinet Components segment. | (3) Contains a portion of the NA Fenestration segment and the NA Cabinet Components segment. | (3) Contains a portion of the NA Fenestration segment and the NA Cabinet Components segment. | (3) Contains a portion of the NA Fenestration segment and the NA Cabinet Components segment. | (3) Contains a portion of the NA Fenestration segment and the NA Cabinet Components segment. | (3) Contains a portion of the NA Fenestration segment and the NA Cabinet Components segment. | (3) Contains a portion of the NA Fenestration segment and the NA Cabinet Components segment. |

---

**QUANEX BUILDING PRODUCTS CORPORATION**

**SALES ANALYSIS**

(In thousands)

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended October 31,** | **Three Months Ended October 31,** | **Twelve Months Ended October 31,** | **Twelve Months Ended October 31,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **Hardware Solutions:<sup>(1)</sup>** |  |  |  |  |
| Window and door hardware | $141303 | $146187 | $552825 | $146187 |
| Screens | 77545 | 75677 | 280814 | 279804 |
| Other | 8035 | 1848 | 8035 | 1848 |
|  | $226883 | $223712 | $841674 | $427839 |
| **Extruded Solutions:<sup>(2)</sup>** |  |  |  |  |
| Window profiles | $73526 | $62058 | $278399 | $255816 |
| Seals and gaskets | 18601 | 21321 | 80916 | 21321 |
| Spacers | 52673 | 51714 | 199217 | 198475 |
| Solar | 6245 | 9598 | 24080 | 25672 |
| Flashing Tape | 3074 | 4751 | 9825 | 18263 |
| Window and door hardware | 10032 | 11177 | 39726 | 11177 |
| Other | 4452 | 19516 | 14464 | 29271 |
|  | $168603 | $180135 | $646627 | $559995 |
| **Custom Solutions:<sup>(3)</sup>** |  |  |  |  |
| Wood solutions | $51648 | $52761 | $200104 | $198424 |
| Access solutions | 27746 | 25792 | 101904 | 25792 |
| Mixing solutions | 24007 | 22687 | 86202 | 85225 |
|  | $103401 | $101240 | $388210 | $309441 |
| **Unallocated Corporate & Other:** |  |  |  |  |
| Eliminations | $(9041) | $(12926) | $(38870) | $(19413) |
|  | $(9041) | $(12926) | $(38870) | $(19413) |
| **Net Sales** | $489846 | $492161 | $1837641 | $1277862 |
| (1) Reflects an increase of $2.5 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (1) Reflects an increase of $2.5 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (1) Reflects an increase of $2.5 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (1) Reflects an increase of $2.5 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (1) Reflects an increase of $2.5 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. |
| (2) Reflects an increase of $2.5 million and $5.4 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (2) Reflects an increase of $2.5 million and $5.4 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (2) Reflects an increase of $2.5 million and $5.4 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (2) Reflects an increase of $2.5 million and $5.4 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (2) Reflects an increase of $2.5 million and $5.4 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. |
| (3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. |
| (3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. | (3) Reflects an increase of $0.2 million in revenue associated with foreign currency exchange rate impacts for the three and twelve months ended October 31, 2025, respectively. |

---